Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: BASi | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: BASi

Revenues up 17% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BASi
 
4Q Revenues: $6.4 million (+17%)

4Q Loss: $404,000 (earnings were $252,000 4Q13)

YTD Revenues: $24.6 million (+11%)

YTD Loss: $1.1 million (earnings were $773,000 YTD13)

Comments: Service revenue for the quarter was up 23% to $4.9 million, due to an increase in Preclinical services studies offset slightly by lower Bioanalytical services revenue. Product revenue was flat at $1.5 million. Impairment charges of $374,000 impacted results in the quarter and FY.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics